药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Chloroprocaine
Cilazaprilat
The risk or severity of angioedema can be increased when Temsirolimus is combined with Cilazaprilat.
Chloroprocaine
Prucalopride
The serum concentration of Prucalopride can be increased when it is combined with Temsirolimus.
Chloroprocaine
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Temsirolimus.
Chloroprocaine
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Temsirolimus.
Chloroprocaine
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Temsirolimus.
Chloroprocaine
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Temsirolimus.
Chloroprocaine
Brentuximab vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Temsirolimus.
Chloroprocaine
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Temsirolimus.
Chloroprocaine
Armodafinil
The metabolism of Temsirolimus can be increased when combined with Armodafinil.
Chloroprocaine
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Temsirolimus.
Chloroprocaine
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Temsirolimus.
Chloroprocaine
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Temsirolimus.
Chloroprocaine
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Temsirolimus.
Chloroprocaine
Roflumilast
Roflumilast may increase the immunosuppressive activities of Temsirolimus.
Chloroprocaine
Idelalisib
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Idelalisib.
Chloroprocaine
Tetrandrine
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Tetrandrine.
Chloroprocaine
Vilanterol
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Vilanterol.
Chloroprocaine
Ruxolitinib
The risk or severity of adverse effects can be increased when Temsirolimus is combined with Ruxolitinib.
Chloroprocaine
Thiotepa
The risk or severity of adverse effects can be increased when Thiotepa is combined with Temsirolimus.
Chloroprocaine
Ciclesonide
The risk or severity of adverse effects can be increased when Ciclesonide is combined with Temsirolimus.